Europe Smart Inhalers Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
to 2027 - Regional Analysis and Forecasts by Product (Nebulizers and Inhalers); Disorder (Chronic Obstructive Pulmonary Disease (COPD), and Asthma); End User (Home-Care Settings and Hospitals & Clinics), and Country

No. of Pages: 111    |    Report Code: TIPRE00006804    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Smart Inhalers Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Smart Inhalers Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Smart Inhalers Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Growing Prevalence of Respiratory Diseases Among the Global Population Drives the Smart Inhalers Market
5.2 Market Opportunities
  • 5.2.1 Increasing Product Development Activities wll be the trend the Smart Inhalers Market
5.3 Future Trends
  • 5.3.1 Rising Rate Of Tobacco Smokers Drives the Smart Inhalers Market
5.4 Impact of Drivers and Restraints

6. Europe Smart Inhalers Market Regional Analysis

6.1 Europe Smart Inhalers Market Overview
6.2 Europe Smart Inhalers Market Revenue 2016-2027 (US$ Million)
6.3 Europe Smart Inhalers Market Forecast Analysis

7. Europe Smart Inhalers Market Analysis – by Product

7.1 Nebulizers and Inhalers
  • 7.1.1 Overview
  • 7.1.2 Nebulizers and Inhalers: Europe Smart Inhalers Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Smart Inhalers Market Analysis – by Disorder

8.1 Chronic Obstructive Pulmonary Disease
  • 8.1.1 Overview
  • 8.1.2 Chronic Obstructive Pulmonary Disease : Europe Smart Inhalers Market – Revenue and Forecast to 2027 (US$ Million)

9. Europe Smart Inhalers Market Analysis – by End User

9.1 Home-Care Settings and Hospitals & Clinics
  • 9.1.1 Overview
  • 9.1.2 Chronic Obstructive Pulmonary Disease : Europe Smart Inhalers Market – Revenue and Forecast to 2027 (US$ Million)

10. Europe Smart Inhalers Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Smart Inhalers Market Breakdown, by Key Country, 2019 and 2027 (%)
  • 10.1.1.1 Europe Smart Inhalers Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Smart Inhalers Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 UK: Europe Smart Inhalers Market Breakdown, by Product
    • 10.1.1.1.2 UK: Europe Smart Inhalers Market Breakdown, by Disorder
    • 10.1.1.1.3 UK: Europe Smart Inhalers Market Breakdown, by End User
  • 10.1.1.2 Germany: Europe Smart Inhalers Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Smart Inhalers Market Breakdown, by Product
    • 10.1.1.2.2 Germany: Europe Smart Inhalers Market Breakdown, by Disorder
    • 10.1.1.2.3 Germany: Europe Smart Inhalers Market Breakdown, by End User
  • 10.1.1.3 France: Europe Smart Inhalers Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 France: Europe Smart Inhalers Market Breakdown, by Product
    • 10.1.1.3.2 France: Europe Smart Inhalers Market Breakdown, by Disorder
    • 10.1.1.3.3 France: Europe Smart Inhalers Market Breakdown, by End User
  • 10.1.1.4 Russia: Europe Smart Inhalers Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Smart Inhalers Market Breakdown, by Product
    • 10.1.1.4.2 Russia: Europe Smart Inhalers Market Breakdown, by Disorder
    • 10.1.1.4.3 Russia: Europe Smart Inhalers Market Breakdown, by End User
  • 10.1.1.5 Italy: Europe Smart Inhalers Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Smart Inhalers Market Breakdown, by Product
    • 10.1.1.5.2 Italy: Europe Smart Inhalers Market Breakdown, by Disorder
    • 10.1.1.5.3 Italy: Europe Smart Inhalers Market Breakdown, by End User
  • 10.1.1.6 Rest of Europe: Europe Smart Inhalers Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Smart Inhalers Market Breakdown, by Product
    • 10.1.1.6.2 Rest of Europe: Europe Smart Inhalers Market Breakdown, by Disorder
    • 10.1.1.6.3 Rest of Europe: Europe Smart Inhalers Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Smart Inhalers Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 GlaxoSmithKline plc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Adherium Ltd.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Vectura Group plc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Novartis AG
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Findair Sp. z o. o.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Cohero Health
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Crux Product Design Ltd
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Teva Pharmaceuticals
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 3M
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Amiko Digital Health Limited
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - E Market

The List of Companies - Europe Smart Inhalers Market

  1. GlaxoSmithKline plc
  2. Adherium Ltd.
  3. Vectura Group plc
  4. Novartis AG
  5. Findair Sp. z o. o.
  6. Cohero Health
  7. Crux Product Design Ltd
  8. Teva Pharmaceuticals
  9. 3M
  10. Amiko Digital Health Limited

 

europe-smart-inhalers-market